Kiely John

SEC Form 4 insider

Amneal Pharmaceuticals, Inc. ($AMRX)

1 thesis · first seen Aug 14, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	0	0	0	—	—	—
3d	1	1	0	0%	+1.5%	+1.5%
1w	1	1	1	100%	-1.3%	-1.3%
1m	0	0	0	—	—	—
3m	0	0	0	—	—	—
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$AMRXSEC Form 4bearish

Kiely John · Amneal Pharmaceuticals, Inc. · 47d agono track record yet

Sold 50,000 @ $17.64 avg · $882,000 · 2026-08-13

Form 4: Kiely John sold AMRX

Kiely John (Director at Amneal Pharmaceuticals, Inc.) reported an open-market sale of 50,000 shares of AMRX at an average $17.64, roughly $882,000, in a Form 4 filed 2026-08-14.

At post $18.15Now $18.71+3.1% since postedas of Sep 18, 4:30 PM ET

1d—

3d+1.5%

1w-1.3%

1m-6.3%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.